Jacobson Pharma Corporation Limited reported earnings results for the half year ended September 30, 2022. For the half year, the company reported sales was HKD 817.35 million compared to HKD 750.41 million a year ago. Net income was HKD 136.19 million compared to HKD 80.04 million a year ago.

Basic earnings per share from continuing operations was HKD 0.071 compared to HKD 0.0418 a year ago.